Gene · 310
NIH grants567
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1 to 20 of 567
| Grant | Title | ANXA7 papers | Newest fiscal year |
|---|---|---|---|
| P30CA068485 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 3 | 2025 |
| ZIAAG000975 | ALZHEIMERS RESEARCH PROJECT / CLINICAL PROJECT: Mechanistic and clinical studies in Alzheimer's disease and related disorders | 3 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 2 | 2025 |
| P30CA022453 | CANCER CENTER SUPPORT GRANT | 2 | 2025 |
| P30CA124435 | Stanford Cancer Institute | 2 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 2 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 2 | 2025 |
| R35GM119768 | Spatial determinants in lipid metabolic organization at the sub-organelle level | 2 | 2025 |
| ZIAHD001607 | Protein Trafficking In The Endosomal-Lysosomal System | 2 | 2025 |
| K12CA133250 | OSU K12 Training Grant in Oncology | 1 | 2025 |
| P01CA022443 | Molecular Biology and Genetics of Human Tumor Viruses | 1 | 2025 |
| P01CA163227 | Androgen Receptor Action in Castration Resistant Prostate Cancer | 1 | 2025 |
| P20GM103436 | IDeA Networks of Biomedical Research Excellence in Kentucky | 1 | 2025 |
| P20GM103449 | Vermont Biomedical Research Network-Vermont INBRE | 1 | 2025 |
| P20GM103451 | New Mexico IDeA Networks of Biomedical Research Excellence (INBRE) | 1 | 2025 |
| P20GM121176 | Autophagy, Inflammation and Metabolism (AIM) in Disease Center - Phase 2. | 1 | 2025 |
| P20GM121293 | Center for Translational Pediatric Research | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-13-0.2.1
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/310/grants